These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
60687-0787 Market Analysis and Financial Projection
The drug associated with NDC 60687-0787 is Digoxin Tablet (125mcg) manufactured by American Health Packaging[10]. Below is a market analysis and price projection for this product:
Market Analysis
Global Digoxin Market Trends
The global Digoxin market was valued at $60 million in 2021 and is projected to reach $74 million by 2030, growing at a CAGR of 3.1%[12][16].
Growth is driven by rising cardiovascular disease prevalence, particularly heart failure and atrial fibrillation[12][17].
However, digoxin usage in the U.S. declined by 47% from 2010–2017, reflecting shifting treatment preferences toward newer therapies[18].
Pricing Dynamics
Retail price for 100 tablets of 125mcg digoxin ranges from $40.77 to $113.11, depending on pharmacy and discounts[13][15].
Prices surged temporarily in 2013–2015 but stabilized at elevated levels post-2015[18].
Generic dominance: Over 90% of digoxin prescriptions are for generics, with American Health Packaging competing in unit-dose adherence packaging[10][12].
Regional Insights
North America dominates sales due to high cardiovascular disease rates and aging populations[12][17].
Demand persists in underserved demographics (e.g., low-income and Hispanic/Asian populations)[18].
Price Projections
Factor
Impact on Pricing
Production costs
Stable due to mature manufacturing processes[12].
Demand trends
Declining usage offset by niche needs in refractory heart failure[18].
Regulatory changes
Minimal impact expected (no new exclusivity or patents)[15].
Competition
High generic competition limits price hikes[13][16].
Short-term (2025–2027): Prices likely to remain flat ($0.40–$0.90 per tablet).
Long-term (2030): Moderate increase to $0.50–$1.20 per tablet due to inflation and specialized adherence packaging demand[10][16].
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
